|
Market Closed -
Sao Paulo
20:22:47 02/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 298.53 BRL | -3.99% |
|
-8.34% | +7.73% |
| 10-02 | S&P 500 Posts Slight Weekly Drop as Health Care, Financials Weigh | MT |
| 10-01 | Wells Fargo Adjusts Price Target on Incyte to $128 From $116, Keeps Equalweight Rating | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| INCYTE CORPORATION | Biopharmaceuticals | -3.99% | -8.34% | +7.73% | +33.95% | +64.05% | 23.37B |
-
|
-
|
-
|
- Stock Market
- Stocks
- INCY Stock
- I1NC34 Stock
- Charts Incyte Corporation
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
